2-(5-methoxy-1H-indol-3-yl)-N,N-dimethylethanamine;2-(5-methoxy-1H-indol-3-yl)-N,N-dimethyl-ethanamine;2-(5-methoxy-1H-indol-3-yl)ethyl-dimethyl-amine;1019-45-0;PDSP2_000032;Maybridge3_000045;1H-Indole-3-ethanamine, 5-methoxy-N,N-dimethyl-;3-[2-(N,N-Dimethylamino)ethyl]-5-methoxyindole;Indole, 3-[2-(N,N-dimethylamino)ethyl]-5-methoxy-;Indole, 3-[2-(dimethylamino)ethyl]-5-methoxy-;NSC88624;WLN: T56 BMJ D2N1&1 GO1;N,N-Dimethyl-5-methoxy tryptamine;PDSP1_000447;SMR000059066;SBB003367;Lopac-M-2381;1H-Indole-3-ethanamine, 5-methoxy-N,N-dimethyl- (9CI);3-(2-(N,N-Dimethyl)aminoethyl)-5-methoxyindole;3-(2-Dimethylaminoethyl)-5-methoxyindole;5-22-12-00027 (Beilstein Handbook Reference);5-Methoxy-N,N-dimethyl-1H-indole-3-ethanamine;5-Methoxy-N,N-dimethyl-1H-indole-3-ethylamine;5-Methoxydimethyltryptamine;BRN 0164771;Bufotenine, O-methyl-;CT 4334;EINECS 213-813-2;Indole, 3-(2-(dimethylamino)ethyl)-5-methoxy-;Indole, 3-(2-(dimethylamino)ethyl)-5-methoxy- (8CI);MeODMT;Methoxybufotenin;Methylbufotenine;N,N-Dimethyl-5-methoxytryptamine;NSC 88624;O-Methylbufotenine;IDI1_011432;3-[2-(Dimethylamino)ethyl]-5-methoxyindole;MLS000069438;Methoxydimethyltryptamines;NCGC00015654-01;PDSP2_000445;SDCCGMLS-0003129.P003;Lopac0_000724;2-(5-methoxy-1H-indol-3-yl)-N,N-dimethylethanamine;NCGC00023288-04;PDSP1_000032;5-Methoxy-DMT;5-OMe-DMT;M2381_SIGMA;5-Methoxy-N,N-dimethyltryptamine;C08309;Indole, 3-(2-(N,N-dimethylamino)ethyl)-5-methoxy-;Oprea1_596468
2-(5-methoxy-1H-indol-3-yl)-N,N-dimethylethanamine